Brand family
Phesgo
United States
- Presentations
- 2
- Markets
- 1
Phesgo is a brand of Hyaluronidase (human recombinant), Pertuzumab and Trastuzumab marketed by Genentech, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Hyaluronidase (human recombinant), Pertuzumab and Trastuzumab
- Brand owner
- Genentech
- Registered in
- United States
- Strengths and forms
- 20000 units/600 mg/600 mg per 10 mL injection, 30000 units/1200 mg/600 mg per 15 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Phesgo 20000 units/600 mg/600 mg per 10 mL injectionSubcutaneous Cold chain | Genentech | US FDA | Available on request |
| Phesgo 30000 units/1200 mg/600 mg per 15 mL injectionSubcutaneous Cold chain | Genentech | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Phesgo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.